ANDREA COSTANTINI

Has grant

Assistant Professor of Clinical Immunology

Università Politecnica delle Marche

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Residual immune activation and evolution of human immunodeficiency virus type 1 (HIV-1) env V3 sequence in HIV-infected and HIV/HCV co-infected patients undergoing integrase inhibitors (INI)- including combined antiretroviral therapy (cART) versus protease inhibitors (PI)- or non nucleoside reverse transcriptase inhibitors (NNRTI)-including cART.

Open Date: 2017-01-01

Close Date: 2018-12-01

Articles (12)

Year:

2023

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

ITALY

View details

VALENTINA SVICHER

University of Rome Tor Vergata

ITALY

View details

GIOVANNI FRANCESCO PELLICANO'

PROFESSORE ASSOCIATO

Università degli Studi di Bari

ITALY

View details

GIULIA CARLA MARCHETTI

University of Milan

ITALY

View details

Francesca Ceccherini-Silberstein

University of Rome Tor Vergata

ITALY

View details

Antonella Poloni

Università Politecnica delle Marche

ITALY

View details

spinello antinori

Full Professor of Infectious Diseases

University of Milan

ITALY

View details

Elda Righi

Associate Professor

University of Verona

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

ANDREA COSTANTINI

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (12)

Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study.

Is HCV elimination among persons living with HIV feasible? Data from the NoCo study in the setting of the ICONA cohort

SARS-CoV-2 mRNA Vaccine Response in People Living with HIV According to CD4 Count and CD4/CD8 Ratio

Correction to: Inflammation and microbial translocation measured prior to combination antiretroviral therapy (cART) and long-term probability of clinical progression in people living with HIV.

Inflammation and microbial translocation measured prior to combination antiretroviral therapy (cART) and long-term probability of clinical progression in people living with HIV.

The impact of DAA-mediated HCV eradication on CD4<sup>+</sup> and CD8<sup>+</sup> T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort.

Corrigendum to: Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease-associated spondyloarthritis.

HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients.

Evaluation of HIV Transmission Clusters among Natives and Foreigners Living in Italy.

Response to: Letter to the Editor on "Bonafè M, Prattichizzo F, Giuliani A, Storci G, Sabbatinelli J, Olivieri F. Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes. Cytokine Growth Factor Rev" by Eugenia Quiros-Roldan, Giorgio Biasiotto and Isabella Zanella.

A novel method to evaluate prethawing viability of cryopreserved CD34+ hematopoietic stem cells for autologous transplantation.

Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease-associated spondyloarthritis.

Collaborators (12)

Vincenzo Esposito

Antonella d'Arminio Monforte

Anna Maria AZZINI

Simone Lanini

Camilla Tincati

VALENTINA SVICHER

GIOVANNI FRANCESCO PELLICANO'

GIULIA CARLA MARCHETTI

Francesca Ceccherini-Silberstein

Antonella Poloni

spinello antinori

Elda Righi

Make your next move.